Chantal Parpex joined CDC Entreprises Innovation in 2004. She holds a Doctorate in Medicine, and a diploma from the Cedep-INSEAD International General Management Program. Dr. Parpex has over 20 years experience in the pharmaceutical industry (notably with the Synthélabo, Rhône Poulenc Rorer and Servier companies). From 1985 to 1997, within the Rhône Poulenc Rorer group, Dr Parpex first held the position of Development Director at Laboratoires Spécia, and then became Managing Director of the Rhône DPC Europe joint venture and VP Corporate Marketing for a range of therapeutic sectors. After having managed clinical and pre-clinical development for Servier, Dr. Parpex joined Gemini Consulting as Principal Consultant in 1999. In the year 2000, Chantal Parpex created and managed Biogestion (Bioam funds).